Abveris Again Named as One of the Best Places to Work in 2022
Abveris Named as One of the Best Places to Work
Canton, MA—March 10, 2022—The Business...
Speaker
Tracey Mullen, CEO of Abveris
Topics of Discussion
• Rapid, efficient discovery of monoclonal antibodies against traditionally difficult targets, including cell surface receptors with complex specificity and functionality requirements
• The advantages of the Abveris single cell workflow (enabled by the Berkeley Lights Beacon®) as compared to other B cell screening platforms
• The advantages of incorporating genetically modified hyperimmune mouse models (DiversimAb™) into in vivo antibody discovery workflows that can greatly increase the likelihood of identifying antibodies binding non-immunodominant, functionally relevant epitopes
• A case study highlighting rapid antibody discovery against a cell surface receptor for which functional activity was paramount to success
Here are more on-demand webinars that our team has put together for you
Abveris Named as One of the Best Places to Work
Canton, MA—March 10, 2022—The Business...